Total Funding
72
59
Total FundingDebt Financing raised
Growth Score
-6 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
33826
Alvogen develops, manufactures, and markets pharmaceutical products, including generics and injectables.
Acquired by 
Lotus Pharmaceutical
- Róbert Wessman: ChairmanPast Role: Actavis, President and CEO
- Eeling Chan: Regional Controller, Asia Pacific
About the Company
Alvogen is a pharmaceutical company that develops and manufactures medicines. The company's portfolio includes generics, brand products, biosimilars, and injectables. Alvogen engages in in-licensing, marketing, and research and development for its pipeline.
